SE0002822L - Elektropulver - Google Patents

Elektropulver

Info

Publication number
SE0002822L
SE0002822L SE0002822A SE0002822A SE0002822L SE 0002822 L SE0002822 L SE 0002822L SE 0002822 A SE0002822 A SE 0002822A SE 0002822 A SE0002822 A SE 0002822A SE 0002822 L SE0002822 L SE 0002822L
Authority
SE
Sweden
Prior art keywords
powder
electro
substance
medical
dry powder
Prior art date
Application number
SE0002822A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE516555C2 (sv
SE0002822D0 (sv
Inventor
Thomas Nilsson
Lars-Gunnar Nilsson
Original Assignee
Microdrug Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdrug Ag filed Critical Microdrug Ag
Priority to SE0002822A priority Critical patent/SE0002822L/
Publication of SE0002822D0 publication Critical patent/SE0002822D0/xx
Priority to US09/636,548 priority patent/US6696090B1/en
Priority to PCT/SE2001/001682 priority patent/WO2002011803A1/en
Priority to KR10-2003-7001612A priority patent/KR20030038685A/ko
Priority to AU8274301A priority patent/AU8274301A/xx
Priority to AU2001282743A priority patent/AU2001282743B2/en
Priority to CNB018168515A priority patent/CN100435879C/zh
Priority to JP2002517135A priority patent/JP2004505685A/ja
Priority to PL01360126A priority patent/PL360126A1/xx
Priority to BR0112903-1A priority patent/BR0112903A/pt
Priority to CA002417225A priority patent/CA2417225A1/en
Priority to RU2003101912/15A priority patent/RU2003101912A/ru
Priority to EP01961481A priority patent/EP1309369A1/en
Publication of SE516555C2 publication Critical patent/SE516555C2/sv
Publication of SE0002822L publication Critical patent/SE0002822L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0002822A 2000-08-04 2000-08-04 Elektropulver SE0002822L (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE0002822A SE0002822L (sv) 2000-08-04 2000-08-04 Elektropulver
US09/636,548 US6696090B1 (en) 2000-08-04 2000-08-11 Electro-powder
EP01961481A EP1309369A1 (en) 2000-08-04 2001-07-27 Electro-powder
CNB018168515A CN100435879C (zh) 2000-08-04 2001-07-27 电粉末
KR10-2003-7001612A KR20030038685A (ko) 2000-08-04 2001-07-27 전기-파우더
AU8274301A AU8274301A (en) 2000-08-04 2001-07-27 Electro-powder
AU2001282743A AU2001282743B2 (en) 2000-08-04 2001-07-27 Electro-powder
PCT/SE2001/001682 WO2002011803A1 (en) 2000-08-04 2001-07-27 Electro-powder
JP2002517135A JP2004505685A (ja) 2000-08-04 2001-07-27 電気的粉末
PL01360126A PL360126A1 (en) 2000-08-04 2001-07-27 Electro-powder
BR0112903-1A BR0112903A (pt) 2000-08-04 2001-07-27 Pó eletrostático
CA002417225A CA2417225A1 (en) 2000-08-04 2001-07-27 Electro-powder
RU2003101912/15A RU2003101912A (ru) 2000-08-04 2001-07-27 Электропорошок

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0002822A SE0002822L (sv) 2000-08-04 2000-08-04 Elektropulver

Publications (3)

Publication Number Publication Date
SE0002822D0 SE0002822D0 (sv) 2000-08-04
SE516555C2 SE516555C2 (sv) 2002-01-29
SE0002822L true SE0002822L (sv) 2002-01-29

Family

ID=20280628

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002822A SE0002822L (sv) 2000-08-04 2000-08-04 Elektropulver

Country Status (12)

Country Link
US (1) US6696090B1 (zh)
EP (1) EP1309369A1 (zh)
JP (1) JP2004505685A (zh)
KR (1) KR20030038685A (zh)
CN (1) CN100435879C (zh)
AU (2) AU8274301A (zh)
BR (1) BR0112903A (zh)
CA (1) CA2417225A1 (zh)
PL (1) PL360126A1 (zh)
RU (1) RU2003101912A (zh)
SE (1) SE0002822L (zh)
WO (1) WO2002011803A1 (zh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SI1494732T1 (sl) 2002-03-20 2008-08-31 Mannking Corp Inhalacijski aparat
SE524990C2 (sv) * 2002-04-12 2004-11-09 Microdrug Ag Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
JP3691459B2 (ja) * 2002-06-14 2005-09-07 久光メディカル株式会社 粉末状吸入剤組成物
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
EP1659918B1 (en) 2003-08-08 2009-01-14 Amgen Fremont Inc. Antibodies directed to parathyroid hormone (pth) and uses thereof
JP2007509981A (ja) * 2003-10-31 2007-04-19 テバ ファーマシューティカル インダストリーズ リミティド 薬物デリバリー用ナノ粒子
JP5078014B2 (ja) 2004-08-20 2012-11-21 マンカインド コーポレイション ジケトピペラジン合成の触媒反応
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
EP1928423B1 (en) 2005-09-14 2015-12-09 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US8297959B2 (en) * 2006-05-03 2012-10-30 Terapia Celular, Ln, Inc. Systems for producing multilayered particles, fibers and sprays and methods for administering the same
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
UY31235A1 (es) * 2007-07-21 2009-03-02 Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
KR101558026B1 (ko) 2008-06-13 2015-10-06 맨카인드 코포레이션 건조 분말 흡입기 및 약물 투여 시스템
CA2728523C (en) 2008-06-20 2020-03-10 Mannkind Corporation An interactive apparatus and method for real-time profiling of inhalation efforts
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
US8650937B2 (en) 2008-09-19 2014-02-18 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
JP5341532B2 (ja) 2009-01-19 2013-11-13 第一電子工業株式会社 １対の誤嵌合防止キー及び該キーを用いた電気コネクタ
JP5498960B2 (ja) 2009-01-19 2014-05-21 三菱瓦斯化学株式会社 エレクトロスプレーにより薬剤を生体内へ注入する方法及び装置
AU2010278894B2 (en) 2009-07-30 2014-01-30 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
CA2801936C (en) 2010-06-21 2021-06-01 Mannkind Corporation Dry powder drug delivery system and methods
KR101940832B1 (ko) 2011-04-01 2019-01-21 맨카인드 코포레이션 의약 카트리지용 블리스터 패키지
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2776053A1 (en) 2011-10-24 2014-09-17 MannKind Corporation Methods and compositions for treating pain
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
WO2016067252A1 (en) 2014-10-31 2016-05-06 Glaxosmithkline Intellectual Property Development Limited Powder formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3268533D1 (en) * 1981-07-24 1986-02-27 Fisons Plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
KR100394052B1 (ko) * 1994-10-04 2003-09-19 더 프록터 앤드 갬블 캄파니 입자재료를정전기분무하는방법
US6214300B1 (en) * 1994-12-02 2001-04-10 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microencapsulation and electrostatic processing device
US5714007A (en) * 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
US5858099A (en) * 1996-04-09 1999-01-12 Sarnoff Corporation Electrostatic chucks and a particle deposition apparatus therefor
GB9616047D0 (en) * 1996-07-31 1996-09-11 Glaxo Group Ltd Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
SE512433C2 (sv) * 1998-07-30 2000-03-13 Microdrug Ag Förfarande för finfördelning och elektrostatisk uppladdning av ett pulver avsett för administrering främst genom inhalation jämte anordning för matning, finfördelning och elektrostatisk uppladdning av ett pulver avsett för administrering främst genom inhalation
SE512386C2 (sv) * 1998-07-30 2000-03-06 Microdrug Ag Förfarande och anordning för klassificering av elektrostatiskt laddat pulverformigt material
US6372246B1 (en) * 1998-12-16 2002-04-16 Ortho-Mcneil Pharmaceutical, Inc. Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals
US6328033B1 (en) * 1999-06-04 2001-12-11 Zohar Avrahami Powder inhaler
US6406745B1 (en) * 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby

Also Published As

Publication number Publication date
PL360126A1 (en) 2004-09-06
BR0112903A (pt) 2003-07-01
SE516555C2 (sv) 2002-01-29
CN1468120A (zh) 2004-01-14
WO2002011803A1 (en) 2002-02-14
SE0002822D0 (sv) 2000-08-04
AU2001282743B2 (en) 2005-04-07
KR20030038685A (ko) 2003-05-16
CA2417225A1 (en) 2002-02-14
RU2003101912A (ru) 2004-07-10
CN100435879C (zh) 2008-11-26
US6696090B1 (en) 2004-02-24
JP2004505685A (ja) 2004-02-26
EP1309369A1 (en) 2003-05-14
AU8274301A (en) 2002-02-18

Similar Documents

Publication Publication Date Title
SE0002822D0 (sv) Electro-powder
Kreuter et al. Distribution and elimination of poly (methyl methacrylate) nanoparticles after subcutaneous administration to rats
MX9404762A (es) Composiciones para inhalacion y proceso para su preparacion.
DE69936730D1 (de) Pharmazeutische aerosolzubereitung, die hfa227 und hfa 134a enthält
FI945621A0 (fi) Säädetysti vapauttava valmiste
ATE367802T1 (de) Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
AU1054399A (en) Soft-pellet drug and process for the preparation thereof
DE60137452D1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
JP6042696B2 (ja) 防已含有組成物
CN107184407A (zh) 一种柔滑保湿造粒洁颜粉及其制备方法
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
SE0003082D0 (sv) Metered electro-dose
EA200500387A1 (ru) Композиции для ингаляции с высоким содержанием лекарственных веществ
PT1186292E (pt) Preparados solidos com estrutura multinuclear
JPH0441421A (ja) 肺吸収組成物
UA80872C2 (uk) Фармацевтична композиція, що містить як активну речовину платиновий комплекс, і спосіб її виготовлення
Kim et al. Chamaecyparis obtusa suppresses virulence genes in Streptococcus mutans
HUP9900521A2 (hu) Eljárás nagyon kis dózisú hatóanyagok szilárd dózisformáinak előállítására
JP2002265388A (ja) 経皮吸収促進剤
GEP20053581B (en) Pharmaceutical Composition and Method for Preparation Thereof
Curran et al. SYSTEMIC AND PULMONARY EXPOSURE OF PUR1900 FOLLOWING INHALATION DOSING IN RATS AND DOGS OVER 28 DAYS
KR100219439B1 (ko) 녹용 캅셀제
Masliy et al. Study of physico-chemical and technological properties of active substances in the composition of medicated chewing gum
Reepmeyer et al. Liquid chromatographic determination of thalidomide in tablets, capsules, and raw materials